"I don't think we will hear too much about DKD or COPD anytime...

"I don't think we will hear too much about DKD or COPD anytime soon....."
Correct, coz it wouldn't be a surprise at all if both have been abandoned.

>>>The 200 drug, compared to other drugs that are shining in nephrology, has pretty mediocre efficacy (based on protein in urine). Can never be 100% on these things but I think it'll be found out as the study goes on. No chance in DKD, the game's moved on big time (check out all the ozempic news in DKD), these guys have taken far too long to execute since the failed DKD trial of several years ago.
>>>COPD drug- does that even exist?? I read the company ANNs - for months they were talking about starting clinical trial H1 2023, then the last thing in jAN 2023 quarter was they were conducting PK/dose work to decide if they "support entry of asset into clinic". Then....er nothing. Do you reckon they did these, if so what did they show, and if there has been silence is it because perhaps they did not support entry of the asset into clinic?? the fact they've not announced anything could imply nothing was done, but then why say to the market you're doing something if you're not?